Pfizer Covid Pill With HIV Drug Cuts the Risk of Hospitalization or Death by 89%, Says Pfizer


Pfizer had come up with a second Covid 19 pill. It is said that this Friday, they have come up with a pill that is very easy to administer. This is a Covid-19 pill that can be administered to people orally. The pill that had been created is known to be in combination with a widely used HIV drug.

This is indeed some of the biggest news. It is now going to cut the risk of hospitalization, and there are also some of the death by 89% of the rate and the stats. This is for the people who have been exposed to the high virus.

Pfizer Covid Pill With HIV Drug Cuts the Risk of Hospitalization or Death by 89%, Says Pfizer

It is now known to the world as the second antiviral pill for the Covid 19 that we had seen. It is just known to be behind Merck’s corona pill that had been given the authorization in the United Kingdom. This is very well and good for the news of the world.

The pill is known to have been provided to demonstrate some of the strong effects that we can get for treating Covid to be found early and then again cured at the first sign of illness. It is still under regulations, and it needs to be reviewed too.

This can be done, and then if it seems that it needs to be cleared by regulators. It would seem that the world is going on ahead and causing a game-changing moment in the pandemic fight.

“There are some of the data presents that seems to suggest the fact that our oral antiviral candidate. Thus this is how it is needed to approve by regulatory authorities,” Pfizer CEO Albert Bourla said in a statement.

Pfizer will submit all the data to the food and drug administration or the commonly known as the FDA. This is going to be then reviewed by the people. Pfizer’s coronavirus pill, which is known scientifically as PF-07321332. That’s all for now.

We hope that we will get some more of the info soon. We are keeping our fingers crossed that this pill seems to work out on the people. That is all. We will be sure to keep you updated.


Please enter your comment!
Please enter your name here